Management of thymoma-associated pure red cell aplasia: A novel use of blood substitute HBOC-201 in a Jehovah's Witness.

TitleManagement of thymoma-associated pure red cell aplasia: A novel use of blood substitute HBOC-201 in a Jehovah's Witness.
Publication TypeJournal Article
Year of Publication2020
AuthorsRubinstein MM, Goss C, Avecilla ST, Dubé GP, Riely GJ, Mones JV
JournalClin Case Rep
Volume8
Issue2
Pagination289-292
Date Published2020 Feb
ISSN2050-0904
Abstract

Pure red cell aplasia (PRCA) is a rare paraneoplastic syndrome occasionally associated with thymomas. Here, we report on the first ever use of a bovine hemoglobin-based oxygen carrier, HBOC-201 (HbO2 Therapeutics LLC; Hemopure, Waltham, MA) for the supportive management of pure red cell aplasia in a Jehovah Witness patient.

DOI10.1002/ccr3.2626
Alternate JournalClin Case Rep
PubMed ID32128175
PubMed Central IDPMC7044386
Grant ListP30 CA008748 / CA / NCI NIH HHS / United States
Related Faculty: 
Cheryl Goss, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700